These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8920485)

  • 1. Routes of administration for bioactive drugs.
    Reddy IK; Banga AK
    J Pract Nurs; 1996 Sep; 46(3):43-8; quiz 49-50. PubMed ID: 8920485
    [No Abstract]   [Full Text] [Related]  

  • 2. Microemulsions for improved peptide absorption from the gastrointestinal tract.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):205-20. PubMed ID: 2051845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic barriers to peptide and protein absorption.
    Lee VH
    Crit Rev Ther Drug Carrier Syst; 1988; 5(2):69-97. PubMed ID: 3052875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the future of noninvasive routes for protein- and peptide-based drugs?
    Sachdeva S; Lobo S; Goswami T
    Ther Deliv; 2016 Jun; 7(6):355-7. PubMed ID: 27250539
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
    Gedulin BR; Smith PA; Jodka CM; Chen K; Bhavsar S; Nielsen LL; Parkes DG; Young AA
    Int J Pharm; 2008 May; 356(1-2):231-8. PubMed ID: 18291606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral peptide delivery: improving the systemic availability of small peptides and enkephalin analogs.
    Lee HJ; Amidon GL
    NIDA Res Monogr; 1995; 154():86-106. PubMed ID: 8606751
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
    Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging strategies for the transdermal delivery of peptide and protein drugs.
    Schuetz YB; Naik A; Guy RH; Kalia YN
    Expert Opin Drug Deliv; 2005 May; 2(3):533-48. PubMed ID: 16296773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery systems for biopharmaceuticals.
    Davis SS
    J Pharm Pharmacol; 1992 Feb; 44 Suppl 1():186-90. PubMed ID: 1348281
    [No Abstract]   [Full Text] [Related]  

  • 10. Multifunctional matrices for oral peptide delivery.
    Bernkop-Schnürch A; Walker G
    Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some approaches to improve bioavailability of peptides and proteins through oral and other mucosal routes.
    Vyas SP; Venugopalan P; Sood A; Mysore N
    Pharmazie; 1997 May; 52(5):339-45. PubMed ID: 9183784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of peptide and peptidomimetic drugs.
    Amidon GL; Lee HJ
    Annu Rev Pharmacol Toxicol; 1994; 34():321-41. PubMed ID: 8042854
    [No Abstract]   [Full Text] [Related]  

  • 13. The anatomy of access: peptide drug delivery.
    Edgington SM
    Biotechnology (N Y); 1991 Dec; 9(12):1326-31. PubMed ID: 1367763
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
    Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides.
    Kamei N; Morishita M; Takayama K
    J Control Release; 2009 Jun; 136(3):179-86. PubMed ID: 19250953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
    Su SF; Amidon GL; Lee HJ
    Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravail: highly effective intranasal delivery of peptide and protein drugs.
    Maggio ET
    Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.
    Salamat-Miller N; Johnston TP
    Int J Pharm; 2005 Apr; 294(1-2):201-16. PubMed ID: 15814245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helodermin-loaded nanoparticles: characterization and transport across an in vitro model of the follicle-associated epithelium.
    des Rieux A; Fievez V; Momtaz M; Detrembleur C; Alonso-Sande M; Van Gelder J; Cauvin A; Schneider YJ; Préat V
    J Control Release; 2007 Apr; 118(3):294-302. PubMed ID: 17292503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of topical peptides in preventing or treating aged skin.
    Gorouhi F; Maibach HI
    Int J Cosmet Sci; 2009 Oct; 31(5):327-45. PubMed ID: 19570099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.